Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals, including adeno-associated virus (AAV) gene therapies, as well as related consulting activities, project management and regulatory support.
Microbiology Product Areas
Pharmaceutical
Adeno-associated virus (AAV)
Show all suppliersATMP - Advanced Therapeutic Medicinal Products
Show all suppliersCell and Gene Therapies
Show all suppliersContract Research Organization (CRO)
Show all suppliersGene and Cell Therapies
Show all suppliersLATEST MICROBIOLOGY NEWS
-
myLIMS Achieves ISO 27001 Certification
15 Dec 2025
MICROBIOLOGY EVENTS
-
10th Anniversary Microbiome Movement Summit
27 Jan 2026 -
Redefining Bacillus cereus Testing: An Innovative Solution for Today’s Challenges
28 Jan 2026 -
WHX Labs Dubai
9 Feb 2026 -
World Water-tech Innovation Summit
24 Feb 2026 -
2026 QC Micro Summit
17 Mar 2026 -
Advanced Therapies
17 Mar 2026 -
Analytica 2026
24 Mar 2026 -
ESCMID Global 2026
17 Apr 2026 -
FoodRevolution® 2026
11 May 2026 -
ASM Microbe 2026
4 Jun 2026